Status:
COMPLETED
Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV)
Lead Sponsor:
University of California, Los Angeles
Conditions:
Hepatitis C
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
The Alcohol Use Reduction in Methadone Individuals with HCV was designed to compare three different types of programs for methadone maintained men and women to determine which of the three programs is...
Detailed Description
Nationwide, major strides have been made in treatment for HCV-infected patients using pegylated interferon and ribaviron; however use of these medications with HCV-infected opioid maintained (OM) IDUs...
Eligibility Criteria
Inclusion
- Eligible participants will be 18 - 55 years of age, enrolled at the participating methadone maintenance clinic for the past 2 months, and moderate to heavy alcohol users within the last 3 months
Exclusion
- Individuals who are not within the age range, have not been enrolled in a methadone maintenance clinic for the past 2 months and were not moderate to heavy alcohol users within the last 3 months
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT00958763
Start Date
March 1 2006
End Date
December 1 2008
Last Update
August 13 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Matrix Institute
Los Angeles, California, United States, 90016
2
Bay Area Addiction Research & Treatment, Inc (BAART)
Los Angeles, California, United States, 90057
3
Tri-City Institute
Los Angeles, California, United States, 90061